🔬 Their goal? Improve cell and gene therapy manufacturing.
💡 They aim to combine lipid-based microbubbles with automated processing technology.
⚙️ This innovation simplifies cell selection and boosts production efficiency.
🏥 Ultimately, it seeks to deliver affordable therapies for patients faster.
Introduction:
The article discusses a collaborative initiative between Bracco Imaging, Limula, and the University of Fribourg aimed at enhancing the manufacturing process for cell and gene therapies. This partnership seeks to overcome current manufacturing challenges, which hinder the widespread adoption of these advanced therapies.
- Bracco Imaging and Limula are launching a research project with Dr. Nicola Vannini to innovate cell manipulation methods.
- Cell selection and activation are critical challenges in the manufacturing of therapies, prompting the need for new solutions.
- The collaboration combines lipid-based microbubbles and automated processing technologies to optimize conventional manufacturing methods.
- This partnership aims to reduce manufacturing complexity and improve patient outcomes by enhancing cell manipulation precision.
- The innovative technologies promise simpler quality control measures and potentially greater product yields and purity.
Conclusion:
The collaboration between Bracco Imaging, Limula, and the University of Fribourg exemplifies a multidisciplinary approach to solving pressing challenges in cell and gene therapy manufacturing. The anticipated innovations not only aim to improve the efficiency of cell processing but also promise to increase the accessibility and affordability of lifesaving therapies for a wider patient demographic in the future.
